Becton, Dickinson and Company
BDX
#480
Rank
$51.811 B
Marketcap
United States
Country
$190.21
Share price
4.85%
Change (1 day)
23.67%
Change (1 year)
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides…
Key Metrics
Trailing P/E
31.44
Forward P/E
13.65
EPS (TTM)
$5.77
Forward EPS
$13.29
Price / Book
2.02
EV / EBITDA
10.7x
Beta
0.28
Dividend Yield
2.31%
Return on Equity
6.61%
Return on Assets
4.34%
Debt / Equity
68.84
Current Ratio
0.86
Gross Margin
46.94%
Operating Margin
15.73%
Net Profit Margin
4.19%
Free Cash Flow
$4.478B
Charts
Price history and financial performance over time.
Price & Market Cap
Aug 19 – Sep 17
-3.32%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$21.840B
Latest Net Income$1.678B
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare Becton, Dickinson and Company with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
BDX
No recent news available. Set FINNHUB_API_KEY to enable news.
